Categories: News

CannaNova LLC Announces its Formation; CannaNova will Commercialize Consumer Cannabinoid Consumables Using DepoFilm™ Oral Film Technology

CannaNova Cannabinoid Film

Cannabinoid Film (CannaNova)

Greensboro, NC, July 19, 2022 (GLOBE NEWSWIRE) — CannaNova Cannabinoid Film

CannaNova LLC today announced its formation to pursue the consumer cannabinoid space, employing DepoFilm™ technology.   With DepoFilm™, CannaNova manufactures buccal consumer cannabinoid films.

CannaNova’s mission is to apply drug delivery principles and its second-generation oral film technology, DepoFilm™, to develop and market high performance cannabis consumables.

CannaNova CEO, Joseph Fuisz, commented:  “CannaNova is using DepofIlm™ technology to address the key challenges that consumer cannabinoid products face today.  These include: slow onset, low bioavailability, and inconsistent bioavailability from patient to patient.  We also believe many adult consumers prefer a non-confectionary format.”

“We believe that rapid onset is particularly advantageous to allow adult consumers to enjoy consumer cannabinoids at the desired dose.  Slow onset is fundamentally at odds with dose titration.   Too frequently, consumers take extra edibles while mistakenly confusing slow onset for having taken too small of a dose.”

“Our hemp-derived products will be sold in eight count child-resistant blister cards.”

CannaNova CSO, Madhu Hariharan, commented: “We are excited to bring our next generation film technology, DepoFilm™, to the consumer cannabinoid category.  Cannanova was formed to leverage our drug delivery expertise and patented technology for the consumer cannabinoid sector.”

“Consumers prefer our fast onset, mucoadhesive, buccal films over traditional means of consuming cannabinoids.” 

“In addition to these advantages, DepoFilm™ technology also enables us to make compelling, highly brandable film shapes, reflecting the quality of our products for adult consumers.”

CannaNova plans to launch a limited test market under its DeltaFilm™ brand.

About CannaNova LLC:  

CannaNova LLC develops, manufactures and markets cannabinoid consummables for adult consumers using patented DepoFilm™ technology.   CannaNova is a private company with its headquarters in Greensboro, NC.  www.cannanova.co

Attachment

CONTACT: jfuisz@fuisz.com


Staff

Recent Posts

PreveCeutical Announces Up-Sized Non-Brokered Private Placement

Vancouver, British Columbia--(Newsfile Corp. - April 14, 2025) - PreveCeutical Medical Inc. (CSE: PREV) (OTCQB:…

2 hours ago

10x Genomics to Report First Quarter 2025 Financial Results on May 8, 2025

PLEASANTON, Calif., April 14, 2025 /PRNewswire/ -- 10x Genomics, Inc. (Nasdaq: TXG), a leader in single cell…

6 hours ago

Lifetech Resources CEO Shaffiq Rahim Delivers Keynote at 2025 Moorpark Chamber of Commerce Momentum and Impact Dinner

MOORPARK, Calif., April 14, 2025 /PRNewswire/ -- Lifetech Resources is proud to announce that its…

6 hours ago

BlackDoctor.org Appoints Akinwole (Aki) Garrett as President & COO to Lead Next Phase of Growth

CHICAGO, April 14, 2025 /PRNewswire/ -- BlackDoctor.org (BDO), the nation's leading health and wellness destination…

6 hours ago

ACR Statement on JAMA CT Scan Radiation Study (Smith-Bindman, et al)

RESTON, Va., April 14, 2025 /PRNewswire/ -- The theoretical radiation risk proposed by Smith-Bindman, et…

6 hours ago

Minutes of IMPLANET’s Annual General Meeting Held on April 11, 2025

BORDEAUX, France & BOSTON--(BUSINESS WIRE)--Regulatory News: IMPLANET (Euronext Growth : ALIMP, FR0013470168, éligible PEA-PME), a…

9 hours ago